随着年龄的增长,GABA水平下降:一项纵向研究
Mark D Zuppichini1, Abbey M Hamlin2, Quan Zhou1
1Department of Psychology, University of Michigan, Ann Arbor, MI, United States.
Imaging neuroscience (Cambridge, Mass.)
|August 13, 2025
概括
健康的衰老可能包括大脑主要的抑制性神经递质胺酸 (GABA) 的下降. 这项纵向研究发现,随着年龄的增长,GABA水平在个体内下降.
科学领域:
- 神经科学是一个神经科学.
- 衰老研究研究 衰老研究
- 神经化学 神经化学
背景情况:
- 在健康的老年人中,功能性衰退可能与降低的胺黄油酸 (GABA) 水平有关.
- 之前的横截面研究对健康衰老期间的GABA变化产生了不一致的发现.
- 与衰老相关的脑缩可能使GABA水平差异的解释复杂化.
研究的目的:
- 在健康的老年人中研究GABA水平的纵向变化.
- 为了确定GABA是否随着时间的推移在老年人中下降.
- 评估组织组成对老化中的GABA测量的影响.
主要方法:
- 采用重复措施的纵向设计,使用30名健康的老年人.
- 使用磁共振 (MR) 光谱测量GABA在特定的大脑区域 (听觉,感觉运动,视觉).
- 应用了组织校正策略,以考虑灰色和白色物质体积变化.
主要成果:
- 纵向分析显示,随着参与者的年龄增长,GABA水平显著下降.
- 在GABA中没有观察到明显的横截面与年龄相关的差异.
- 组织校正的GABA水平在个体内随着时间的推移显然下降.
结论:
- 这项研究提供了在健康衰老过程中GABA在人体内下降的证据.
- 纵向数据对于理解与年龄相关的神经递质变化至关重要.
- 对组织组成的控制加强了与年龄相关的GABA减少的发现.
更多相关视频
07:42Combined Transcranial Magnetic Stimulation and Electroencephalography of the Dorsolateral Prefrontal Cortex
Published on: August 17, 2018
11.9K
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
13.8K
相关概念视频
Long-term Depression
2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.6K
Longitudinal Research
12.5K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.5K
Stages of General Anesthesia
698
Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
698
Cognitive Development During Adulthood
275
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
275
Antiepileptic Drugs: GABAergic Pathway Potentiators
646
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
646
Alzheimer's Disease: Overview
668
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
668
